Nanocarriers Nanoparticles for transport and delivery of active components

These delivery particles are characterised by an innovative architecture with a dendritic core and a multilayer shell. Due to their uni-molecular structure the nanocarriers are much more stable than micelles which have been widely discussed for nano-transportation so far. The multilayer design allows the specific adjustment of the carrier to the loaded substances. The shell is tied to the core by molecular linkers and shields the encapsulated molecules. The linkers are accessible to changes of the micro-environment, so that selective targeting is possible. The nanocarriers are stable in a neutral environment, for example, while they degrade when being exposed to an acidic pH-value.

Further Information: PDF

PROvendis GmbH
Phone: +49 (0)208/94105 0

Contact
Dipl.-Ing. Alfred Schillert

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Chimpanzee in a tropical forest demonstrating genetic adaptations for survival.

Parallel Paths: Understanding Malaria Resistance in Chimpanzees and Humans

The closest relatives of humans adapt genetically to habitats and infections Survival of the Fittest: Genetic Adaptations Uncovered in Chimpanzees Görlitz, 10.01.2025. Chimpanzees have genetic adaptations that help them survive…

Fiber-rich foods promoting gut health and anti-cancer effects.

You are What You Eat—Stanford Study Links Fiber to Anti-Cancer Gene Modulation

The Fiber Gap: A Growing Concern in American Diets Fiber is well known to be an important part of a healthy diet, yet less than 10% of Americans eat the minimum recommended…

RNA-binding protein RbpB regulating gut microbiota metabolism in Bacteroides thetaiotaomicron.

Trust Your Gut—RNA-Protein Discovery for Better Immunity

HIRI researchers uncover control mechanisms of polysaccharide utilization in Bacteroides thetaiotaomicron. Researchers at the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Julius-Maximilians-Universität (JMU) in Würzburg have identified a…